World's Best Scientists 2026 revealed!
Therapeutic Drug Monitoring
H-index 19

Therapeutic Drug Monitoring

0163-4356

Published by: Wolters Kluwer Health

https://journals.lww.com/drug-monitoring/pages/default.aspx

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1575 54 95 16

Additional Metrics

Number of Best Scientists*: 117
Documents by Best Scientists*: 166
Top 100 Ranked Scientists*: 0
SCIMAGO H-index: 105
SCIMAGO SJR: 0.585
Impact Factor: 2.4

Overview

Top Research Topics at Therapeutic Drug Monitoring?

The journal mainly tackles studies in Pharmacokinetics, Pharmacology, Chromatography, Internal medicine and Therapeutic drug monitoring. The concepts on Pharmacokinetics presented in the journal can also apply to other research fields, including Oral administration, Anesthesia, Surgery, Urology and Anticonvulsant. While Anticonvulsant is the focus of it, it also provided insights into the studies of Carbamazepine and Phenytoin.

Some problems in Pharmacology that were presented in it overlapped with concepts under Mycophenolic acid, Tacrolimus and Toxicity. Metabolite and Immunoassay are some topics wherein Chromatography research discussed in Therapeutic Drug Monitoring have an impact. The work on Internal medicine tackled in the journal brings together disciplines like Gastroenterology, Endocrinology and Oncology.

The studies on Therapeutic drug monitoring discussed can also contribute to research in the domains of Dosing, Transplantation and Intensive care medicine. It focuses on High-performance liquid chromatography research which is adjacent to topics in Extraction (chemistry).

  • Pharmacokinetics (30.78%)
  • Pharmacology (29.10%)
  • Chromatography (26.58%)

What are the most cited papers published in the journal?

  • METLIN: a metabolite mass spectral database. (1560 citations)
  • Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls. (416 citations)
  • Organophosphate pesticides: biochemistry and clinical toxicology. (370 citations)

Research areas of the most cited articles at Therapeutic Drug Monitoring:

The published papers primarily focus on research topics in Pharmacology, Pharmacokinetics, Therapeutic drug monitoring, Internal medicine and Chromatography. The published articles explore issues in Pharmacology which can be linked to other research areas like Metabolite, Pharmacogenetics and Anticonvulsant. The most cited papers deal with Pharmacokinetics in conjunction with Transplantation and similar fields in Area under the curve.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Pharmacology
  • Diabetes mellitus

The previous edition focused in particular on these issues:

The objective of Therapeutic Drug Monitoring is to combine knowledge in the areas of Therapeutic drug monitoring, Pharmacokinetics, Internal medicine, Dosing and Chromatography. The featured Therapeutic drug monitoring study falls within the wider topic of Pharmacology. Topics in Pharmacology explored in Therapeutic Drug Monitoring were investigated in conjunction with research in Antibiotics, Lopinavir and Ritonavir.

It focuses on Pharmacokinetics but the discussions also offer insight into other areas such as Anesthesia, Urology, Drug and Renal function. Internal medicine research presented in Therapeutic Drug Monitoring encompasses a variety of subjects, including Gastroenterology, Endocrinology and Oncology. Therapeutic Drug Monitoring explores issues in Dosing which can be linked to other research areas like Creatinine, Medical physics, Bayesian probability and Teicoplanin.

The most cited articles from the last journal are:

  • A Review of Synthetic Cathinone-Related Fatalities From 2017 to 2020. (6 citations)
  • Is Europe Facing an Emerging Opioid Crisis Comparable to the U.S. (6 citations)
  • Alternative Sampling Devices to Collect Dried Blood Microsamples: State-of-the-Art (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Therapeutic Drug Monitoring (based on the number of publications) are:

  • Gideon Koren (107 papers) absent at the last edition,
  • Michael Oellerich (75 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Victor W. Armstrong (74 papers) absent at the last edition,
  • Raymond G. Morris (63 papers) absent at the last edition,
  • Paul J. Taylor (58 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Therapeutic Drug Monitoring (based on the number of publications) are:

  • University of Toronto (83 papers) published 1 paper at the last edition,
  • Erasmus University Rotterdam (60 papers) published 3 papers at the last edition, 5 less than at the previous edition,
  • Boston Children's Hospital (58 papers) published 4 papers at the last edition, 1 less than at the previous edition,
  • University of Queensland (51 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Karolinska Institutet (46 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 13.79% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 14.00% were posted by at least one author from the top 10 institutions publishing in the journal. Another 2.00% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 19.00% of all publications and 65.00% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Educational Impact Of Therapeutic Drug Monitoring

An essential aspect that the article does not mention is the educational impact of the Therapeutic Drug Monitoring journal on its readers and contributors. Understanding how educational development is facilitated through research can help recognize the importance of such journals in pushing the boundaries of knowledge and practice in fields like Pharmacokinetics, Pharmacology, and Internal medicine.

The field of Therapeutic Drug Monitoring covers a vast number of areas in medicine and pharmacology that form the backbone of many educational curriculums in medical schools. As it generates new findings in these areas, many institutions include these updates in their syllabus to provide their students with up-to-date knowledge about the field. One of the significant beneficiaries of this practice is those enrolled in Nursing schools since they lean heavily on Pharmacology and Pharmacokinetics among other subjects.

A prime example of how this journal impacts educational curriculums is seen in the top 10 best nursing schools in Minnesota. These schools not only encourage their students to read and contribute to Therapeutic Drug Monitoring, but the research published in this journal also heavily influences their Pharmacology and Pharmacokinetics course structure and content. Therefore, it plays a pivotal role in training the next generation of healthcare providers to be adequately equipped to deal with various pharmacological challenges they may encounter in their practice.

In conclusion, the educational impact of Therapeutic Drug Monitoring extends far beyond the confines of its reader base, and it substantially shapes the direction of medical education, particularly in Nursing schools. Its impact, therefore, cannot be understated and is an imperative component that enhances the depth of this article.

Top Publications

  • Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

    Stein Bergan;Mercè Brunet;Dennis A. Hesselink;Kamisha L. Johnson-Davis

    (2021)
    132 Citations
  • A review of synthetic cathinone-related fatalities from 2017 to 2020.

    (2020)
    93 Citations
  • Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19

    (2022)
    65 Citations
  • Is Europe Facing an Emerging Opioid Crisis Comparable to the U.S.

    Jan van Amsterdam;Mimi Pierce;Wim van den Brink

    (2021)
    60 Citations
  • Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.

    Laure Elens;Loralie J. Langman;Dennis A. Hesselink;Stein Bergan

    (2020)
    53 Citations
  • Therapeutic Drug Monitoring of Antibiotics: Defining the Therapeutic Range

    Mohd H Abdul-Aziz;Kara Brady;Menino Osbert Cotta;Jason A Roberts

    (2021)
    44 Citations
  • Pregnancy Alters CYP- and UGT-Mediated Metabolism of Buprenorphine.

    Hongfei Zhang;Jaime R Bastian;Wenchen Zhao;Huijun Chen

    (2020)
    35 Citations
  • Future Studies on the Interaction Between Clozapine and Valproic Acid Should Aspire to Include Longitudinal Designs and Free Valproate Concentrations, and Should Consider that Inducer and/or Inhibitory Effects May Vary With Time, the Individual, and the Auto-Induction of Valproic Acid.

    Jose de Leon

    (2020)
    33 Citations
  • Usage of Tacrolimus and Mycophenolic Acid During Conception, Pregnancy, and Lactation, and Its Implications for Therapeutic Drug Monitoring: A Systematic Critical Review

    Hoang Lan Le;Marith I Francke;Louise M Andrews;Brenda C M de Winter

    (2020)
    32 Citations
  • Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical Review.

    Evelina Cardoso;Monia Guidi;Benoît Blanchet;Marie Paule Schneider

    (2020)
    28 Citations

Related Online Degrees & Career Pathways

For students interested in Medicine, exploring related online degrees can open diverse career opportunities beyond becoming a physician. One popular pathway is becoming a certified professional coder. This role plays a crucial part in healthcare by accurately translating medical procedures into standardized codes used for billing and insurance claims.

Understanding the financial aspects is important too; many wonder about medical.coder salary prospects when considering this career. While salaries vary by location and experience, medical coding offers a stable income with opportunities for advancement.

If you’re debating whether is medical billing and coding worth it, it’s helpful to weigh the benefits of job flexibility and relatively low education costs against potential challenges, like keeping up with constantly changing regulations.

For those aiming to advance further, pursuing an online health information management degree can broaden career options into healthcare administration and data management, crucial areas in modern medicine.

Best Scientists Contributing to This Journal